Search
Research
The COSI-2 TrialTobias Jenny Strunk Mountain MD, PhD, FRACP MBA MClinEpi Head, Neonatal Health Program Manager, Neonatal Health / Protect Trial tobias.strunk@
-
Research
The Impact of Unfavourable Climatic Conditions on Children and FamiliesThis project aims to explore the impacts of unfavourable climatic conditions on children and families.
Research
The interplay between sarcoma and surgery-induced wound healingIn this project, we are using systems biology approaches to map the wound healing response in sarcoma following surgery to identify new treatments that can prevent sarcoma relapse.
Research
A data infrastructure for improving Aboriginal life pathways: the influence of health, education, child protection and justice systems over time and across generationsIncarceration represents a source of ongoing socioeconomic and health inequity between Aboriginal and non-Aboriginal populations, limiting life changes and opportunities.
Research
Multigenerational disadvantage in AustraliaThis study aims to examine the experience of multiple disadvantages in two generations of Australian families, and how these experiences relate to the trajectories of children, the third generation.
Research
The ORVAC Trial - A phase IV, double-blind, randomised, placebo-controlled clinical trial to optimise the delivery of RV1 rotavirus vaccine to Northern Territory Aboriginal infantsTom Snelling BMBS DTMH GDipClinEpid PhD FRACP Head, Infectious Disease Implementation Research 08 6319 1817 tom.snelling@thekids.org.au Head,
Guide our sibling research!
News & Events
ORIGINS celebrates it’s 10,000th baby, reaching key recruitment milestoneAustralia’s biggest longitudinal study following the health and wellbeing of children from their conception through to childhood, has welcomed its 10,000th and final participant.
News & Events
New trial aims to reduce peanut allergy in childrenMothers eating a diet rich in peanuts while breastfeeding might be helping to reduce their baby’s risk of developing a peanut allergy – that’s the hypothesis of a new clinical trial that has been granted $2.29 million in funding by the National Health and Medical Research Council (NHMRC).